Open AccessThrombolytic retreatment with tissue plasminogen activator for threatened reinfarction and thrombotic coronary reocclusion
Author(s) -
Becker Richard C.
Publication year - 1994
Publication title -
clinical cardiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.263
H-Index - 72
eISSN - 1932-8737
pISSN - 0160-9289
DOI - 10.1002/clc.4960170103
Subject(s) - medicine , thrombolysis , cardiology , tissue plasminogen activator , thrombosis , coronary thrombosis , plasminogen activator , revascularization , myocardial infarction
Following successful coronary arterial thrombolysis, thrombogenic substrate persists, increasing the risk of recurrent thrombosis, reocclusion, and reinfarction. The preferred treatment in this setting has not been established. Although many patients receive mechanical revascularization, it is conceivable that repeat thrombolysis. primarily with tissue plasminogen activator, represents the most readily available and effective alternative.